Current use of polyclonal antilymphocyte antibody preparations
Author:
- 20 September 1999
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 31 (6) , 2208-2209
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- RESULTS OF THE DOUBLE-BLIND, RANDOMIZED, MULTICENTER, PHASE III CLINICAL TRIAL OF THYMOGLOBULIN VERSUS ATGAM IN THE TREATMENT OF ACUTE GRAFT REJECTION EPISODES AFTER RENAL TRANSPLANTATION1,2Transplantation, 1998
- Antibody Induction Therapy in Pancreas TransplantationTransplantation Proceedings, 1998
- The Effect of Antilymphocyte Induction Therapy on Renal Allograft SurvivalAnnals of Internal Medicine, 1998
- Seven-year experience with rabbit antithymocyte globulin after cardiac transplantation at the Montreal Heart InstituteTransplantation Proceedings, 1997
- Lymphocyte subsets during and after rabbit anti-thymocyte globulin induction in pediatric renal transplantation: Sustained T cell depletionTransplantation Proceedings, 1997
- Effect of anti-lymphocyte induction therapy on renal allograft survivalJournal of the American Society of Nephrology, 1997
- Use of thymoglobulin induction therapy in the prevention of acute graft rejection episodes following liver transplantationTransplantation Proceedings, 1997
- A PROSPECTIVE RANDOMIZED TRIAL COMPARING INTERLEUKIN-2 RECEPTOR ANTIBODY VERSUS ANTITHYMOCYTE GLOBULIN AS PART OF A QUADRUPLE IMMUNOSUPPRESSIVE INDUCTION THERAPY FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1997
- ANTILYMPHOCYTE INDUCTION THERAPY IN CADAVER RENAL TRANSPLANTATIONTransplantation, 1997
- Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative StudyPediatric Nephrology, 1997